Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Other Non-Current Assets (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Other Non-Current Assets data on record, last reported at $1.3 million in Q3 2021.

  • For Q3 2021, Other Non-Current Assets changed 0.0% year-over-year to $1.3 million; the TTM value through Sep 2021 reached $1.3 million, changed 0.0%, while the annual FY2020 figure was $1.3 million, 0.0% changed from the prior year.
  • Other Non-Current Assets reached $1.3 million in Q3 2021 per COGT's latest filing, roughly flat from $1.3 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $2.6 million in Q1 2018 and bottomed at $419000.0 in Q3 2018.
  • Average Other Non-Current Assets over 4 years is $1.2 million, with a median of $1.3 million recorded in 2018.
  • The widest YoY moves for Other Non-Current Assets: up 102.15% in 2019, down 51.95% in 2019.
  • A 4-year view of Other Non-Current Assets shows it stood at $1.3 million in 2018, then changed by 0.0% to $1.3 million in 2019, then changed by 0.0% to $1.3 million in 2020, then changed by 0.0% to $1.3 million in 2021.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $1.3 million in Q3 2021, $1.3 million in Q2 2021, and $1.3 million in Q1 2021.